Published in Vaccine Weekly, April 25th, 2012
"We're pleased to have David join Bellicum and bring with him a singularly unique knowledge of the science behind our products," commented Tom Farrell, CEO of Bellicum Pharmaceuticals....
Want to see the full article?
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Vaccine Weekly